Xcout Intel
Shanghai Junshi Biosciences
Shanghai Junshi Biosciences Co., Ltd. is an innovation-driven biopharmaceutical company with its global headquarters in Shanghai, China. The company is dedicated to the discovery and development of innovative drugs, including drug-target identification, and employs approximately 3,000 people worldwide.
Subscribe to see Shanghai Junshi Biosciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Shanghai Junshi Biosciences at a glance
Shanghai Junshi Biosciences is a biotechnology / pharmaceuticals company headquartered in China. Xcout tracks 8 named people at Shanghai Junshi Biosciences, including Patricia KEEGAN (首席医学官).
Shanghai Junshi Biosciences leadership
- Patricia KEEGAN首席医学官
- 李宁执行董事、副董事长
- 李聪执行董事、联席首席执行官
- 王刚执行董事、工业事务高级副总裁/首席质量官
- 王行远首席商务官
- 邹建军执行董事、总经理/首席执行官
2 more named people on record for Shanghai Junshi Biosciences, with roles, board committees and tenure — see the full roster →
Shanghai Junshi Biosciences competitors
A few of Shanghai Junshi Biosciences's closest competitors — see the full list of competitors and alternatives →
Nanjing Zenshine Pharmaceuticals Co., Ltd. is a pharmaceutical manufacturing company focusing on small molecule therapeutics in cancer, viral infection, and other medical fields. It is headquartered in Nanjing, China.
Shanghai Shyndec Pharmaceutical Co., Ltd., established in 1996 and headquartered in Shanghai, China, operates as a pharmaceutical enterprise. The company focuses on the global production of various drug formulations. Its primary therapeutic areas of specialization include anti-infectives, cardiovascular and cerebrovascular treatments, oncology, metabolic disorders, and endocrine system conditions.
Jacobio Pharma is a clinical-stage biopharmaceutical company committed to developing innovative products and targeted therapies to improve human health, including building its KRAS franchise and oncology solutions. Headquartered in Beijing, China, the company operates research and corporate facilities in major domestic hubs.
Shanghai CureGene Pharmaceutical Co., Ltd. is a biopharmaceutical company founded in Zhangjiang, Shanghai, in 2018. It specializes in developing state-of-the-art medications and has built a globally leading targeted prodrug platform.
Established in 2004, Shanghai Allist Pharmaceuticals Co., Ltd. is a Chinese enterprise dedicated to the innovation and development of medicinal products. Headquartered in Shanghai, the company focuses its efforts on creating therapeutic agents specifically for the treatment of various tumor and cancer-related conditions.
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Get Shanghai Junshi Biosciences's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Shanghai Junshi Biosciences in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access